Does Osteoarthritis Cause Inflammation? What the Science Shows

Ask most people what causes osteoarthritis and they will tell you it is the joint wearing out, like the tread on a tire or the hinge on an old door. For most of the twentieth century, that is roughly what doctors believed too. Osteoarthritis was classified as a non-inflammatory, degenerative, mechanical problem, in explicit contrast to the "inflammatory arthritis" of rheumatoid disease. The name even reflected this: many textbooks called it osteoarthrosis, deliberately dropping the "itis" suffix that signals inflammation.

That picture has changed. A large body of molecular, imaging, and clinical research now shows that inflammation is woven through the osteoarthritis process from the start. It is a quieter, more localized inflammation than the kind that defines autoimmune arthritis, but it is real, it is measurable, and it helps explain why some joints deteriorate faster and hurt more than others.

The "Wear and Tear" Myth and What Replaced It

The turning point came from molecular biology, not the clinic. In a widely cited review titled "Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)," rheumatologist Francis Berenbaum traced how discoveries in the 1990s dismantled the purely mechanical view. Researchers found that chondrocytes, the cells that maintain cartilage, respond to stress by releasing cytokines and prostaglandins that ramp up the production of matrix-degrading enzymes. In other words, the cartilage was not just passively eroding; it was participating in its own destruction through inflammatory signaling (Berenbaum, 2013).

It then took roughly another decade for synovitis to be accepted as a core feature. As imaging improved, studies kept finding inflammation of the synovial lining in large numbers of osteoarthritis patients, and that inflammation tracked with cartilage damage and symptoms. Berenbaum's review summarized the shift bluntly: once thought to be driven only by cartilage, osteoarthritis is "a much more complex disease with inflammatory mediators released by cartilage, bone and synovium," with low-grade inflammation from metabolic syndrome, innate immunity, and aging all feeding the process.

The practical importance of this reframing is hard to overstate. If a joint is simply wearing out, there is nothing to do but manage pain and eventually replace it. If inflammation is part of the engine, then the modifiable factors that influence inflammation, body weight, physical activity, diet, and metabolic health, become potential levers on the disease itself.

Where the Inflammation in Osteoarthritis Comes From

Osteoarthritis inflammation is generated inside the joint by the tissues themselves. Unlike an infection, there is no outside invader. Instead, mechanical overload and cartilage breakdown release fragments of damaged tissue, and the innate immune system treats these fragments as danger signals. A comprehensive review of inflammatory mediators in osteoarthritis described how pro-inflammatory cytokines, reactive oxygen species, nitric oxide, and matrix-degrading enzymes, together with biomechanical stress, are the major factors responsible for the progression of disease in the joint (Rahmati, Mobasheri, and Mozafari, 2016).

Three joint tissues drive the inflammatory loop:

• The synovium. When cartilage debris and inflammatory signals reach the synovial lining, it becomes inflamed and thickened and pours out cytokines such as interleukin-1 beta (IL-1 beta), tumor necrosis factor (TNF), and interleukin-6 (IL-6). These molecules feed back onto the cartilage and accelerate its breakdown.
• The cartilage. Chondrocytes under mechanical and inflammatory stress shift from maintaining cartilage to degrading it, producing enzymes like matrix metalloproteinases and aggrecanases that dismantle the cartilage matrix.
• The subchondral bone. The bone beneath the cartilage is not a bystander. It remodels, releases its own inflammatory mediators, and contributes to both pain and the deeper erosion of cartilage.

This self-reinforcing cycle, often called a vicious circle in the research literature, is why osteoarthritis tends to progress once it is established. The inflammation is low grade compared with autoimmune arthritis, but it is persistent, and persistence is what does the damage over years.

How Osteoarthritis Inflammation Differs From Rheumatoid Arthritis

The distinction matters, because the two conditions are often confused. In rheumatoid arthritis, the immune system makes a mistake: it launches a systemic autoimmune attack against the joints, producing intense, body-wide inflammation that typically affects joints symmetrically, is often accompanied by markedly elevated CRP and other markers, and can be driven into remission with drugs that suppress the immune system.

Osteoarthritis inflammation is different in kind, not just degree. It is primarily a local, innate-immune response to mechanical stress and tissue damage, concentrated in the joints that bear load or have been injured. It does not usually involve autoantibodies, it tends to be asymmetric and tied to specific joints such as the knees, hips, hands, and spine, and its systemic inflammatory signal is far more subtle. Both diseases share inflammatory signaling in joint tissue, as the broader arthritis and inflammation picture shows, but the triggers and pathways are distinct. That is why the anti-inflammatory biologic drugs that transform rheumatoid arthritis have generally not worked as hoped in osteoarthritis.

Does Osteoarthritis Raise Your CRP?

This is where the local-versus-systemic distinction becomes practical. C-reactive protein (CRP) is a liver protein that rises in response to IL-6 and other inflammatory signals, and a high-sensitivity version of the test (hs-CRP) can detect the low-grade inflammation that standard tests miss. Because osteoarthritis inflammation is mostly confined to the joint, you might expect it to leave little trace in the blood. The data show a small but genuine signal.

A systematic review and meta-analysis of 32 studies found that serum hs-CRP levels in people with osteoarthritis were modestly but statistically significantly higher than in controls, by an average of 1.19 mg/L (Jin et al., 2015). Crucially, those CRP levels were significantly associated with pain and with decreased physical function, but not with the severity of joint damage seen on X-rays. The authors concluded that low-grade systemic inflammation may play a greater role in symptoms than in the structural, radiographic changes of osteoarthritis.

A separate meta-analysis of 14 studies on knee osteoarthritis reached a complementary conclusion: CRP was higher in people who went on to develop knee osteoarthritis than in controls, and it was significantly higher in patients with the most severe pain, by roughly 1.60 mg/L compared with those in less pain, even though baseline CRP did not predict how fast the joint damage itself progressed (Zhang, 2018). The recurring theme across both analyses is that in osteoarthritis, CRP tracks how a joint feels more closely than how it looks on imaging.

The takeaway is nuanced. A normal CRP does not rule out osteoarthritis, and osteoarthritis is not a condition you would diagnose or stage from a CRP number. But a persistently elevated CRP in someone with joint pain is a signal worth paying attention to, both because it correlates with symptom burden and because it may point to the broader metabolic inflammation discussed next.

The Weight, Metabolism, and Inflammation Connection

One of the strongest arguments for the inflammatory view of osteoarthritis comes from the role of body weight, and it is not only about load. Carrying extra weight does increase mechanical stress on weight-bearing joints, but obesity also raises osteoarthritis risk in non-weight-bearing joints like the hands, which pure mechanics cannot explain. The missing link is that fat tissue is metabolically active and secretes inflammatory signals that circulate throughout the body, a phenomenon explored in depth in the relationship between obesity and inflammation.

Research on the cellular side supports this. A study of women with knee osteoarthritis found that they had elevated serum CRP and more activated circulating monocytes, a type of immune cell, than healthy matched controls. Higher body mass index and higher levels of the cytokine TNF were linked to greater monocyte activation, and that activation in turn correlated with worse pain (Loukov et al., 2018). The researchers suggested that these immune cells are being primed in the bloodstream before they ever reach the joint, implying that systemic, metabolically driven inflammation can feed directly into local joint disease.

This is the concept of "metabolic" osteoarthritis: a version of the disease in which systemic low-grade inflammation, often tied to excess weight and metabolic syndrome, amplifies what is happening inside the joint. It is also the most hopeful part of the story, because metabolic inflammation is one of the most responsive targets available to lifestyle change.

What This Means for Managing Osteoarthritis

Understanding osteoarthritis as partly inflammatory does not mean inflammation is the whole story, but it does widen the toolkit. Alongside the standard measures of staying active within comfort, strengthening the muscles around a joint, and working with a clinician on pain, the inflammatory model highlights several levers that act on the biology rather than just the symptoms.

Weight management is the best supported. For people carrying extra weight, losing it reduces both the mechanical load on joints and the systemic inflammatory signaling from fat tissue. Studies of weight loss in knee osteoarthritis consistently show improvements in pain and function, and the effect is larger when weight loss is combined with exercise than with either alone.

Movement is medicine, within reason. Regular, joint-appropriate physical activity has a genuine anti-inflammatory effect and helps maintain the cartilage-supporting muscles around a joint. The old instinct to rest an arthritic joint has given way to evidence that controlled activity usually helps more than it hurts. For specific guidance on this, our overview of how to reduce inflammation in your joints goes into practical detail.

Diet quality shapes the inflammatory baseline. An eating pattern rich in vegetables, fruit, whole grains, legumes, fish, and olive oil, and lower in ultra-processed foods and added sugar, is associated with lower levels of inflammatory markers. No diet reverses established cartilage loss, but a lower inflammatory baseline is a reasonable goal for anyone managing a condition with an inflammatory component.

None of this replaces medical care. Osteoarthritis that is progressing, severely painful, or limiting daily life deserves evaluation and management by a qualified healthcare provider, and this article is wellness education rather than medical advice.

Tracking Inflammation as Part of the Picture

Because osteoarthritis has a measurable inflammatory dimension that tracks with how joints feel, keeping an eye on your general inflammatory status can be a useful part of a broader healthy-lifestyle effort. CRP reflects the net output of many inputs, including body weight, activity, diet, and metabolic health, which are the same factors that influence the inflammatory side of osteoarthritis.

Sensa is a general wellness tool that lets you check your CRP levels at home, without a needle or a clinic visit, so a measurement becomes a routine data point rather than a rare event. Watching your CRP trend over months as you adjust weight, movement, and diet gives you objective feedback on whether those changes are moving your inflammatory baseline in the right direction. CRP is a wellness insight rather than a diagnosis, and it cannot diagnose or stage osteoarthritis, so persistent elevations or worsening joint symptoms are always worth discussing with a healthcare provider.

The deeper message of the research is encouraging. A joint that is "wearing out" sounds like a one-way street. A joint caught in a cycle that includes inflammation is something you may be able to influence, and the levers that matter most, weight, movement, and diet, are the same ones that shape inflammation throughout the body.

Sources

• Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis and Cartilage, 2013. pubmed.ncbi.nlm.nih.gov/23194896
• Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, Ding C. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Annals of the Rheumatic Diseases, 2015. pubmed.ncbi.nlm.nih.gov/24363360
• Zhang J. Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis. BMC Musculoskeletal Disorders, 2018. pubmed.ncbi.nlm.nih.gov/29351749
• Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. Bone, 2016. pubmed.ncbi.nlm.nih.gov/26812612
• Loukov D, Karampatos S, Maly MR, Bowdish DME. Monocyte activation is elevated in women with knee-osteoarthritis and associated with inflammation, BMI and pain. Osteoarthritis and Cartilage, 2018. pubmed.ncbi.nlm.nih.gov/29128509

Frequently Asked Questions

Is osteoarthritis an inflammatory condition?

Yes, though not in the same way as autoimmune arthritis. Osteoarthritis was long classified as a non-inflammatory, mechanical "wear and tear" disease, but research has shown it involves low-grade inflammation of the joint lining (synovitis) and inflammatory molecules released by cartilage, bone, and synovium that actively drive cartilage breakdown and pain. The inflammation is milder and more localized than in rheumatoid arthritis, but it is a genuine part of the disease process.

Does osteoarthritis raise CRP levels?

Modestly. A meta-analysis of 32 studies found that high-sensitivity CRP was on average 1.19 mg/L higher in people with osteoarthritis than in controls, and that CRP correlated with pain and reduced physical function rather than with the severity of joint damage on X-rays. A normal CRP does not rule out osteoarthritis, and CRP is not used to diagnose or stage it, but an elevated CRP in someone with joint pain is worth noting.

What is the difference between osteoarthritis and rheumatoid arthritis inflammation?

Rheumatoid arthritis is a systemic autoimmune disease in which the immune system attacks the joints, producing intense, body-wide inflammation, usually symmetric joint involvement, and often markedly elevated CRP. Osteoarthritis inflammation is primarily a local, innate-immune response to mechanical stress and tissue damage, concentrated in specific load-bearing or injured joints, without autoantibodies, and with a much more subtle systemic signal.

Can reducing inflammation help osteoarthritis?

Addressing the inflammatory and metabolic side of osteoarthritis through weight management, regular joint-appropriate exercise, and an anti-inflammatory dietary pattern is associated with less pain and better function, and weight loss combined with exercise works better than either alone. These measures do not reverse established cartilage loss, and persistent or worsening symptoms should be evaluated by a healthcare provider.